 |
PDBsum entry 3eu0
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Cysteine s-Nitrosylation protects protein-Tyrosine phosphatase 1b against oxidation-Induced permanent inactivation.
|
 |
|
Authors
|
 |
Y.Y.Chen,
H.M.Chu,
K.T.Pan,
C.H.Teng,
D.L.Wang,
A.H.Wang,
K.H.Khoo,
T.C.Meng.
|
 |
|
Ref.
|
 |
J Biol Chem, 2008,
283,
35265-35272.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Protein S-nitrosylation mediated by cellular nitric oxide (NO) plays a primary
role in executing biological functions in cGMP-independent NO signaling.
Although S-nitrosylation appears similar to Cys oxidation induced by reactive
oxygen species, the molecular mechanism and biological consequence remain
unclear. We investigated the structural process of S-nitrosylation of
protein-tyrosine phosphatase 1B (PTP1B). We treated PTP1B with various NO
donors, including S-nitrosothiol reagents and compound-releasing NO radicals, to
produce site-specific Cys S-nitrosylation identified using advanced mass
spectrometry (MS) techniques. Quantitative MS showed that the active site
Cys-215 was the primary residue susceptible to S-nitrosylation. The crystal
structure of NO donor-reacted PTP1B at 2.6 A resolution revealed that the S-NO
state at Cys-215 had no discernible irreversibly oxidized forms, whereas other
Cys residues remained in their free thiol states. We further demonstrated that
S-nitrosylation of the Cys-215 residue protected PTP1B from subsequent
H(2)O(2)-induced irreversible oxidation. Increasing the level of cellular NO by
pretreating cells with an NO donor or by activating ectopically expressed NO
synthase inhibited reactive oxygen species-induced irreversible oxidation of
endogenous PTP1B. These findings suggest that S-nitrosylation might prevent PTPs
from permanent inactivation caused by oxidative stress.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Application of the quantitative MS method and structural
analysis for identification of the most susceptible Cys residue
of PTP1B to S-nitrosylation. A-D, recombinant PTP1B treated with
1 mm SNAP or 0.01 mm SNAP was subjected to differential isotope
labeling for quantitative MALDI-MS analysis as described in
Scheme 1. The full scan MALDI-MS profile (A) revealed three
pairs of cICAT-labeled tryptic peptides with a 9-Da difference,
which could be assigned to T4, T28, and T15, as shown in
expanded views (B-D), corresponding to the cICAT-labeled peptide
pairs containing Cys-32, Cys-215, or Cys-92, respectively. The
ratio of light/heavyc ICAT-labeled peak is shown below the
spectrum. E, the crystal of PTP1B was soaked with 1 mm SNAP at
room temperature for 20 min and subjected tox-ray
crystallography. The 2F[o] - 2F[c] electron density map showed a
mixture of reduced and S-nitrosylated states of Cys-215. Other
Cys residues (Cys-32, -92, -121, -226, and -231) remained in the
completely reduced form. Inset, the expended view of electron
density map illustrates the presence of an S-nitrosothiol form
of Cys-215.
|
 |
Figure 2.
Protective effect of Cys S-nitrosylation on preventing PTP1B
from further irreversible oxidation. A, recombinant PTP1B was
pretreated with 1 mm N-acetylpencillamine or SNAP for 20 min,
followed by 1 mm H[2]O[2] for 10 min, and then digested by
trypsin in solution. The tryptic peptides were subjected to
LC-nESI-MS analysis. T28 carrying the Cys-215 in Cys-SH,
Cys-SO[2]H, Cys-SO[3]H, and Cys-SNO forms were first identified
by manually examining the nESI-MS profile at the expected
retention time. For a semiquantitative assessment, the extracted
ion chromatograms for the respective signals are plotted in A
without normalization or correcting for nESI-MS response factor.
The amount of the irreversibly oxidized SO[2]H/SO[3]H form
(eluting at 17.7-18.5 min) elicited by 1 mm H[2]O[2] is clearly
reduced to basal level in SNAP-pretreated sample, compared with
N-acetylpencillamine-pretreated sample. The corresponding
nESI-MS profiles for this time point are shown in B, where the
signals identified as the irreversibly oxidized T28 (m/z 736.4
and 741.7) are detectable at increasing intensity when PTP1B was
treated with increasing concentration of H[2]O[2] but not when
it was first S-nitrosylated by SNAP. C, recombinant PTP1B,
either directly exposed to H[2]O[2], SNAP, or GSNO or pretreated
with SNAP or GSNO followed by H[2]O[2] treatment, was subjected
to immunoblotting with an anti-oxidized PTP active site
(anti-oxi-PTP) antibody (top) or an anti-PTP1B antibody (FG6)
(bottom). The effect of SNAP or GSNO on inhibiting the level of
H[2]O[2]-induced irreversible oxidation of PTP1B was observed in
three independent experiments.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2008,
283,
35265-35272)
copyright 2008.
|
 |
|
|
|
|
 |